President Hugo Chavez Denies Rumors Of Kidney Failure
9/29/2011
President Hugo Chavez of Venezuela, who had a tumor "the size of a baseball" removed from his pelvic area earlier on this year in Cuba, and has undergone four bouts of chemotherapy, four in Cuba and one in Venezuela, has denied rumors that he had to be rushed to hospital with kidney failure...
Diabetes Patients Have Higher Colon Cancer Risk
9/29/2011
Patients with diabetes mellitus have a higher risk of developing colon cancer, researchers from the University of California, Berkeley, reported in the American Journal of Gastroenterology. The authors stated that according to their findings, diabetes is an independent risk fact for rectal and colon cancers...
Full Phase II Investigation Data On Metastatic Melanoma Drug PV-10 Reported By Provectus
9/29/2011
Provectus Pharmaceuticals, Inc. presented positive initial data from fully monitored investigation data for all 80 participants in their Phase II clinical trial of the drug PV-10 for metastatic melanoma. In 49% of participants an Objective Response (OR) was observed, with 71% of participants achieving locoregional disease control (stable disease or better) in their injected lesions...
Cancer Waiting Times In The NHS Are Improving, UK
9/29/2011
According to statistics published this month, cancer waiting times have improved over the past year, irrespective of more than 100,000 additional people in England being seen by a cancer specialist and despite a general growing pressure on waiting times in the health service...
Full Phase II Investigation Data On Metastatic Melanoma Drug PV-10 Reported By Provectus
9/29/2011
Provectus Pharmaceuticals, Inc. presented positive initial data from fully monitored investigation data for all 80 participants in their Phase II clinical trial of the drug PV-10 for metastatic melanoma. In 49% of participants an Objective Response (OR) was observed, with 71% of participants achieving locoregional disease control (stable disease or better) in their injected lesions...
Liver Cancer Drug Provectus Receives Orphan Drug Designation From FDA
9/29/2011
The U.S. Food and Drug Administration (FDA) has given orphan drug designation to Provectus Pharmaceuticals, Inc., for Rose Bengal, the active component in their new oncology medication PV-10. The drug is designed for the treatment of hepatocellular carcinoma (HCC), the most prevalent form of liver cancer...
UCLA researchers who analyzed dozens of previously unexamined internal documents from the tobacco industry say tobacco companies developed "deep and intimate" knowledge about the cancer-causing potential of radioactive alpha particles in cigarette smoke but deliberately kept it from the public for more than four decades...
HPV Vaccine Less Likely To Be Recommend By Pediatricians In Appalachia
9/29/2011
Pediatricians in Appalachia are less likely than doctors in other areas to encourage parents to have their children receive the human papillomavirus (HPV) vaccine, according to a new study...
Pre-clinical Research Proves Promising For The Treatment Of Blood Cancer
9/29/2011
Pre-clinical research has generated some very promising findings about a prototype drug for the treatment of chronic lymphocytic leukemia (CLL). The findings, from work carried out by scientists at NUI Galway, are published in this month's Molecular Cancer Therapeutics, a journal of the American Association for Cancer Research...
Improved Collection Of Prostate Cancer Cells Promised By New UC Research
9/29/2011
At the Oct. 2-6 microTAS 2011 conference, the premier international event for reporting research in microfluidics, nanotechnology and detection technologies for life science and chemistry, University of Cincinnati researchers will present a simple, low-cost, method for separating and safely collecting concentrated volumes of fragile prostate cancer cells...